HealthEquity
Market Cap
US$4.3b
Last Updated
2019/11/20 00:33 UTC
Data Sources
Company Financials +
Executive Summary
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States.
Snowflake
Fundamentals
Flawless balance sheet with proven track record.
Similar Companies
Share Price & News
How has HealthEquity's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HQY has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
1.4%
HQY
5.1%
US Healthcare
0.9%
US Market
1 Year Return
-20.4%
HQY
4.3%
US Healthcare
16.8%
US Market
Return vs Industry: HQY underperformed the US Healthcare industry which returned 4.3% over the past year.
Return vs Market: HQY underperformed the US Market which returned 16.8% over the past year.
Shareholder returns
| HQY | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.4% | 5.1% | 0.9% |
| 30 Day | 9.1% | 12.0% | 4.5% |
| 90 Day | 0.6% | 13.5% | 6.2% |
| 1 Year | -20.4%-20.4% | 6.1%4.3% | 19.4%16.8% |
| 3 Year | 41.2%41.2% | 52.6%45.8% | 47.5%38.0% |
| 5 Year | 159.2%159.2% | 69.8%58.2% | 62.0%44.1% |
Price Volatility Vs. Market
How volatile is HealthEquity's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
How Should Investors React To HealthEquity, Inc.'s (NASDAQ:HQY) CEO Pay?2 weeks ago | Simply Wall St
Should You Worry About HealthEquity, Inc.’s (NASDAQ:HQY) ROCE?3 weeks ago | Simply Wall St
What Kind Of Shareholders Own HealthEquity, Inc. (NASDAQ:HQY)?Valuation
Is HealthEquity undervalued compared to its fair value and its price relative to the market?
42.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HQY ($61) is trading below our estimate of fair value ($106.47)
Significantly Below Fair Value: HQY is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HQY is poor value based on its PE Ratio (42.5x) compared to the Healthcare industry average (21.7x).
PE vs Market: HQY is poor value based on its PE Ratio (42.5x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: HQY is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: HQY is overvalued based on its PB Ratio (4.2x) compared to the US Healthcare industry average (2.6x).
Next Steps
Future Growth
How is HealthEquity forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
18.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HQY's forecast earnings growth (18.7% per year) is above the savings rate (2.7%).
Earnings vs Market: HQY's earnings (18.7% per year) are forecast to grow faster than the US market (14.4% per year).
High Growth Earnings: HQY's earnings are forecast to grow, but not significantly.
Revenue vs Market: HQY's revenue (23.1% per year) is forecast to grow faster than the US market (7.3% per year).
High Growth Revenue: HQY's revenue (23.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HQY's Return on Equity is forecast to be low in 3 years time (14.6%).
Next Steps
Past Performance
How has HealthEquity performed over the past 5 years?
46.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HQY has high quality earnings.
Growing Profit Margin: HQY's current net profit margins (28.1%) are higher than last year (23.8%).
Past Earnings Growth Analysis
Earnings Trend: HQY has become profitable over the past 5 years, growing earnings by 46.9% per year.
Accelerating Growth: HQY's earnings growth over the past year (46.4%) is below its 5-year average (46.9% per year).
Earnings vs Industry: HQY earnings growth over the past year (46.4%) exceeded the Healthcare industry 9.7%.
Return on Equity
High ROE: HQY's Return on Equity (8.8%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is HealthEquity's financial position?
Financial Position Analysis
Short Term Liabilities: HQY's short term assets ($853.5M) exceeds its short term liabilities ($37.1M)
Long Term Liabilities: HQY's short term assets ($853.5M) exceeds its long term liabilities (44.2M)
Debt to Equity History and Analysis
Debt Level: HQY is debt free.
Reducing Debt: HQY had no debt 5 years ago.
Debt Coverage: HQY has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: HQY has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: HQY has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if HQY's debt is covered by short term assets.
Next Steps
Dividend
What is HealthEquity's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate HQY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate HQY's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HQY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HQY's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HQY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of HealthEquity's salary, the management and board of directors tenure and is there insider trading?
3.2yrs
Average management tenure
CEO
Jon Kessler (51yo)
5.8yrs
Tenure
US$4,808,670
Compensation
Mr. Jon Kessler has been the Chief Executive Officer and President at HealthEquity, Inc. since February 2014. Mr. Kessler founded WageWorks, Inc., in 2000 and serves as its Chief Executive Officer and Pres ...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD4.81M) is about average for companies of similar size in the US market ($USD5.10M).
Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.
Management Age and Tenure
3.2yrs
Average Tenure
51yo
Average Age
Experienced Management: HQY's management team is considered experienced (3.2 years average tenure).
Board Age and Tenure
5.3yrs
Average Tenure
57yo
Average Age
Experienced Board: HQY's board of directors are considered experienced (5.3 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 3,074 |
| Max Price | US$70.86 |
| Entity | Individual |
| Role | Chief Executive Officer President |
| Shares | 10,000 |
| Max Price | US$61.00 |
| Entity | Individual |
| Role | Vice Chairman Founder & Vice Chairman |
| Shares | 10,000 |
| Max Price | US$61.00 |
| Entity | Individual |
| Role | Chairman of the Board Non-Executive Chairman |
| Shares | 10,000 |
| Max Price | US$61.00 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 10,000 |
| Max Price | US$61.00 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 1,778 |
| Max Price | US$67.78 |
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.
Management Team
Darcy Mott (66yo)
Executive VP & CFO
- Tenure: 12.8yrs
- Compensation: US$1.86m
Jon Kessler (51yo)
President
- Tenure: 5.8yrs
- Compensation: US$4.81m
Stephen Neeleman (51yo)
Founder & Vice Chairman
- Tenure: 5.8yrs
- Compensation: US$1.87m
Jody Dietel
Senior VP of Compliance & Regulatory Affairs
- Tenure: 0.2yrs
Ashley Dreier (46yo)
Executive VP
- Tenure: 6.8yrs
- Compensation: US$2.99m
Brad Bennion
Senior Vice President of Corporate Development
- Tenure: 2.6yrs
Ted Bloomberg (43yo)
Executive VP & COO
- Tenure: 1.3yrs
- Compensation: US$2.46m
Delano Ladd (38yo)
Executive VP
- Tenure: 3.2yrs
- Compensation: US$1.53m
Bill Otten (54yo)
Executive Vice President of Sales
- Tenure: 2.5yrs
- Compensation: US$2.09m
Richard Putnam
Vice President of Investor Relations
- Tenure: 0yrs
Board Members
Adrian Dillon (65yo)
Independent Director
- Tenure: 3.2yrs
- Compensation: US$205.00k
Bob Selander (69yo)
Non-Executive Chairman
- Tenure: 4.2yrs
- Compensation: US$305.00k
Evelyn Dilsaver (63yo)
Independent Director
- Tenure: 5.3yrs
- Compensation: US$245.00k
Frank Corvino (70yo)
Independent Director
- Tenure: 5.3yrs
- Compensation: US$205.00k
Jon Kessler (51yo)
President
- Tenure: 5.8yrs
- Compensation: US$4.81m
Stephen Neeleman (51yo)
Founder & Vice Chairman
- Tenure: 5.8yrs
- Compensation: US$1.87m
Ian Sacks (48yo)
Independent Director
- Tenure: 15.6yrs
- Compensation: US$210.00k
Frank Medici (56yo)
Independent Director
- Tenure: 13.1yrs
- Compensation: US$220.00k
Gayle Wellborn (58yo)
Independent Director
- Tenure: 2.3yrs
- Compensation: US$205.00k
Debra McCowan (47yo)
Independent Director
- Tenure: 1.6yrs
- Compensation: US$343.33k
Company Information
HealthEquity, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: HealthEquity, Inc.
- Ticker: HQY
- Exchange: NasdaqGS
- Founded: 2002
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$4.308b
- Shares outstanding: 70.62m
- Website: https://www.healthequity.com
Number of Employees
Location
- HealthEquity, Inc.
- 15 West Scenic Pointe Drive
- Suite 100
- Draper
- Utah
- 84020
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HQY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jul 2014 |
| 2HE | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jul 2014 |
Biography
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party adm ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/20 00:33 |
| End of Day Share Price | 2019/11/19 00:00 |
| Earnings | 2019/07/31 |
| Annual Earnings | 2019/01/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.